Organon & Co (OGN)

Organon & Co (OGN) is a Drug Manufacturers - General company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $3.6B; returns 1 day +0.0%, 1 week -0.1%, 1 year +51.9%.

Organon & Co. is a global healthcare company that was spun off from Merck & Co. in 2021, specializing in three core pillars: Women’s Health, Biosimilars, and Established Brands.

Groups OGN belongs to

• Dividend Payers
• Healthcare
• Pharmaceuticals
• Women's Health
• Biotechnology
• Biologics
• Generics
• Long-Acting Injectables

OGN financial model: income statement, cash flow and balance sheet